Literature DB >> 11318983

Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels.

J W Cho1, W K Baek, S I Suh, S H Yang, J Chang, Y C Sung, M H Suh.   

Abstract

AIMS/
BACKGROUND: The hepatitis C virus (HCV) core protein is known to play an important role in hepatocarcinogenesis. Recent studies have suggested that the increased proliferation rate of hepatocytes is a major risk factor for the development of hepatocellular carcinoma. In this study, we investigated whether the HCV core protein promotes the cell growth rate through the modulation of cyclin E expression levels. METHODS/
RESULTS: HCV core stable transfectant Rat-1 cell lines showed a markedly increased proliferation rate compared to mock cells. Cyclin E expression and its associated kinase activities were remarkably increased in HCV core stable transfectants. Cyclin E mRNA levels were also upregulated in these cell lines.
CONCLUSIONS: Our data suggest that the HCV core protein promotes cell proliferation through upregulation of the cyclin E expression levels, implying this property of HCV core protein plays an important role in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318983     DOI: 10.1034/j.1600-0676.2001.021002137.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  13 in total

1.  Interaction between hepatitis C virus core protein and translin protein--a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus.

Authors:  Ke Li; Lin Wang; Jun Cheng; Yin-Ying Lu; Ling-Xin Zhang; Jin-Song Mu; Yuan Hong; Yan Liu; Hui-Juan Duan; Gang Wang; Li Li; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 2.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

3.  Differential stimulation of hepatitis C virus RNA translation by microRNA-122 in different cell cycle phases.

Authors:  Carmen Fehr; K Dominik Conrad; Michael Niepmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

4.  Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma.

Authors:  Sarah L Fishman; Stephanie H Factor; Cinzia Balestrieri; Xiaofeng Fan; Adrian M Dibisceglie; Suresh M Desai; Gary Benson; Andrea D Branch
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

5.  Hepatitis C virus core proteins derived from different quasispecies of genotype 1b inhibit the growth of Chang liver cells.

Authors:  Xue-Bing Yan; Lei Mei; Xia Feng; Mei-Rong Wan; Zhi Chen; Nicole Pavio; Christian Brechot
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

6.  Kinase-independent function of E-type cyclins in liver cancer.

Authors:  Yan Geng; Wojciech Michowski; Joel M Chick; Yaoyu E Wang; M Emmanuelle Jecrois; Katharine E Sweeney; Lijun Liu; Richard C Han; Nan Ke; Agnieszka Zagozdzon; Ewa Sicinska; Roderick T Bronson; Steven P Gygi; Piotr Sicinski
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

7.  Expression of RB C pocket fragments in HSF induces delayed cell cycle progression and sensitizes to apoptosis upon cellular stresses.

Authors:  Junah Chung; Jae-We Cho; Won-Ki Baek; Seong-Il Suh; Taeg Kyu Kwon; Jong-Wook Park; Min-Ho Suh
Journal:  Cell Prolif       Date:  2002-08       Impact factor: 6.831

Review 8.  Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.

Authors:  Mohammad Irshad; Priyanka Gupta; Khushboo Irshad
Journal:  World J Hepatol       Date:  2017-12-28

9.  Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm.

Authors:  Cintia Bittar; Shubham Shrivastava; Joydip Bhanja Chowdhury; Paula Rahal; Ratna B Ray
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

Review 10.  Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.

Authors:  C Nelson Hayes; Peiyi Zhang; Yizhou Zhang; Kazuaki Chayama
Journal:  Viruses       Date:  2018-09-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.